COVID-19 IN THE MEDIA


Press releases

January 18, 2021
Grifols begins clinical trial of a new treatment that would provide immediate immunity against COVID-19

October 9, 2020
Grifols' anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19

September 14, 2020
Grifols more committed than ever to its values and long-term vision six months into the pandemic

July 28, 2020
Grifols delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for clinical trials

June 11, 2020
Grifols starts production of its hyperimmune immunoglobulin as a potential passive immune therapy against COVID-19

June 10, 2020
Grifols and Hologic embark on a unique collaboration for COVID-19 testing in Spain

May 5, 2020
Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus

April 21, 2020
Grifols continues to reinforce its commitment to all stakeholders as a response to COVID-19

April 20, 2020
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers

March 25, 2020
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

March 18, 2020
Grifols reinforces its commitment to all stakeholders as a response to the COVID-19 outbreak

Company statements

April 23, 2020
Updated Grifols Corporate Statement on the Novel Coronavirus

March 13, 2020
Updated Grifols Corporate Statement on the Novel Coronavirus

March 4, 2020
Grifols Corporate Statement on the Novel Coronavirus

COVID-19 Coalition

May 26, 2020
Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

Press clipping

Date Media Headline
8 JAN, 2021 Diari ARA Plasma de supervivents com a tractament per al covid-19
12 OCT, 2020 WRAL TechWire At Clayton plant, Grifols begins phase 3 testing for COVID-19 treatment
9 OCT, 2020 La Vanguardia Grifols inicia el ensayo para testar su inmunoglobulina en pacientes con Covid-19
9 OCT, 2020 Expansión Grifols inicia un ensayo clínico contra el Covid-19 con financiación de EEUU
9 OCT, 2020 Cinco Días Grifols inicia los ensayos clínicos de su tratamiento para el Covid-19 en pacientes contagiados del virus
7 OCT, 2020 Fox 13 Salt Lake City Plasma donors are needed to make life-saving medicines that treat rare and chronic conditions
14 SEP, 2020 La Vanguardia Grifols recupera niveles de plasma y aumentará la producción un 30 % en 2021
14 SEP, 2020 El Confidencial Digital Grifols prevé una recuperación total de sus volúmenes de plasma en 2021
25 AUG, 2020 FOX 10 Phoenix Plasma centers in Phoenix looking for more donors who have recovered from COVID-19
24 AUG, 2020 El Periódico La autorización de EEUU al tratamiento del Covid con plasma impulsa a Grifols
24 AUG, 2020 Cinco Días El uso del plasma en EE UU frente al Covid-19 refuerza la acción de Grifols
11 AUG, 2020 EFE Publican una "secuencia consenso" del virus de COVID "clave" para la vacuna
11 AUG, 2020 ABC Científicos del IrsiCaixa descifran la secuencia genética del Covid-19 y avanzan en el estudio de la inmunidad
03 AUG, 2020 WRAL TechWire At Clayton plant, Grifols produces first batch of potential COVID-19 treatment
28 JUL, 2020 North State Journal Grifols delivers first manufactured batches of its coronavirus treatment for clinical trials
28 JUL, 2020 Reuters Grifols entrega los primeros lotes de su medicamento contra COVID-19 para ensayos clínicos
28 JUL, 2020 Expansión Grifols finaliza producción de primeros lotes de inmunoglobulina anti-Covid
28 JUL, 2020 El Economista Grifols entrega sus primeros lotes de su inmunoglobulina hiperinmune para el ensayo clínico contra el coronavirus
28 JUL, 2020 La Vanguardia Grifols finaliza producción de primeros lotes de inmunoglobulina anti-COVID
24 JUN, 2020 Cinco Días La OMS incluye una vacuna de IrsiCaixa y Grifols entre las candidatas frente al virus
24 JUN, 2020 El Economista La OMS incluye el proyecto de Grifols e IrsiCaixa entre los candidatos a la vacuna para el coronavirus
12 JUN, 2020 Johnstonian News Grifols begins production of COVID-19 treatment
12 JUN, 2020 The New York Times Researchers Ask if Survivor Plasma Could Prevent Coronavirus
11 JUN, 2020 NC Biotech Grifols Begins Producing First COVID-19 Drug in Clayton
11 JUN, 2020 WRAL TechWire Grifols begins manufacturing potential COVID-19 treatment at Clayton facility
11 JUN, 2020 Expansión Grifols ya produce su tratamiento potencial para la Covid-19
11 JUN, 2020 RAC1 Grifols comença a produir el seu tractament contra el coronavirus
11 JUN, 2020 La Vanguardia Grifols inicia la producción de inmunoglobulina hiperinmune contra la Covid-19
20 MAY, 2020 WFXL-TV (Georgia) Plasma centers requesting donations from recovered COVID-19 patients
20 MAY, 2020 Idaho News 6 Grifols seeking plasma donations from recovered COVID-19 patients
20 MAY, 2020 KRGV (Texas) Plasma center seeks donations from Valley residents who recovered from coronavirus
18 MAY, 2020 KTVN News Plasma From COVID-19 Survivors Needed for Antibody Treatment
17 MAY, 2020 The Denver Post Colorado doctors using donated plasma to treat coronavirus patients
12 MAY, 2020 CBS Denver Blood Collection Center In Denver Seeking Plasma Donations From Recovered Coronavirus Patients
10 MAY, 2020 RAC1 (Via Lliure) Entrevista a Daniel Fleta, director industrial de Grifols
7 MAY, 2020 KFOX14 (Texas) How to donate plasma after recovering from COVID-19
7 MAY, 2020 TV3 (Tot Es Mou) Nou test molecular de Grífols per detectar la Covid-19
7 MAY, 2020 TVE Informativos 21 h (min. 22)
7 MAY, 2020 Diari Ara "Oferim al Govern tota la nostra capacitat per fer tests, ells decidiran com implementar-la si ho troben adient"
6 MAY, 2020 La Vanguardia España ampliará los diagnósticos de Covid-19 con un nuevo test de Grifols
5 MAY, 2020 Expansión Grifols pondrá a disposición de España 1,5 millones de test la semana viene
28 APR, 2020 UNC-TV (North Carolina) NC company develops treatment for Covid-19
27 APR, 2020 Shoreline Area News (Seattle) Global healthcare company seeking local plasma donors who have recovered from COVID-19
22 APR, 2020 Diari Ara El plasma dels curats: un antídot per als casos més greus de covid-19
21 APR, 2020 The New York Times Grifols Says Anti-Coronavirus Hyperimmune Immunoglobins May Be Ready Mid-July
21 APR, 2020 Fort Worth Star-Telegram (Dallas) Company hopes to find coronavirus treatment with blood from former patients
21 APR, 2020 KUOW (Seattle) Grifols has announced that people who have recovered from Covid-19 can donate their plasma at select Grifols Biomat USA plasma centers
21 APR, 2020 La Vanguardia Grifols se vuelca en el coronavirus: prevé tener listo un test en mayo y un tratamiento en julio
21 APR, 2020 Betevé El Banc de Sang i Teixits rep la solidaritat de 2.000 donants que han passat la covid-19
13 APR, 2020 The Sun Coronavirus survivors donating plasma and taking immunity tests as key to beating virus ‘may be in their blood'
12 APR, 2020 La Vanguardia Grifols o el plasma para la vida
12 APR, 2020 El País Voluntarios corporativos que salvan distancias
4 APR, 2020 TV3 (FAQS) Plasma convalescent i immunoglobulina: el tractament de Grifols per curar la Covid
3 APR, 2020 Associated Press (AP) Coronavirus survivor: ‘In my blood, there may be answers'
2 APR, 2020 Associated Press (AP Videos) Survivor: ‘In my blood, there may be answers'
2 APR, 2020 20 Minutos Arrancan en España los ensayos que usan plasma de 'curados' de coronavirus en pacientes que aún están afectados
2 APR, 2020 RTVE Plasma de pacientes curados contra el COVID-19: "En julio ya podríamos disponer de las primeras dosis en EE.UU."
1 APR, 2020 North State Journal Global healthcare firm to produce first targeted COVID-19 treatment platform in NC
30 MAR, 2020 Ärzte-Zeitung Grifols entwickelt Hyperimmunglobulin
30 MAR, 2020 CCMA Un grup de malalts de Covid-19 millora gràcies al plasma de convalescents
29 MAR, 2020 El País "Ojalá podamos empezar los ensayos en abril"
29 MAR, 2020 El Correo La industria vasca contra la pandemia
27 MAR, 2020 Expansión Grifols cierra su alianza estratégica con la china Shanghai RAAS y anuncia que en julio tendrá lista la inmunoglobina anti-Covid en EEUU
27 MAR, 2020 La Vanguardia El plasma de pacientes curados se utilizará como tratamiento de los más enfermos
27 MAR, 2020 Handelsblatt Forscher wollen Covid-19-Patienten mit Antikörpern von Geheilten behandeln
26 MAR, 2020 Diari Ara "Les autoritats dels EUA tenen clar que això pot funcionar"
26 MAR, 2020 El País - Materia Los donantes de sangre que han superado la COVID-19, nueva esperanza contra la enfermedad
26 MAR, 2020 Europa Press Grifols rebota más de un 6% en Bolsa tras colaborar en ensayos clínicos para combatir el coronavirus
26 MAR, 2020 Expansión Grifols despunta en el Ibex con su estudio de terapias contra el coronavirus
26 MAR, 2020 News & Observer A facility in Clayton will play key role in a potential therapy for COVID-19
26 MAR, 2020 Catalunya Ràdio Grifols: "Analitzar el plasma de persones que han superat el virus permetrà treballar en vacunes"
26 MAR, 2020 La Vanguardia Grifols prevé iniciar en abril un ensayo con plasma para frenar COVID-19
26 MAR, 2020 The New York Times Spain's Grifols to Test Plasma Therapy for COVID-19 With U.S. FDA
26 MAR, 2020 Cinco Días Grifols colabora en EE UU para tratar infectados por coronavirus gracias al plasma con anticuerpos
25 MAR, 2020 Planta Doce Grifols sella un acuerdo con EEUU para producir el primer tratamiento para el Covid-19
25 MAR, 2020 BioCentury COVID-19 roundup: Grifols partners with BARDA, FDA on convalescent plasma; plus Vir, Sorrento, Ascletis, BMS and Ipsen
25 MAR, 2020 Daily Mail Spain's Grifols to Test Plasma Therapy for COVID-19 With U.S. FDA
25 MAR, 2020 Expansión Grifols acuerda con EEUU investigar una cura para el Covid-19
25 MAR, 2020 ElNacional.cat Grifols arriba a un acord amb els EUA per buscar un tractament pel coronavirus
25 MAR, 2020 Johnstonian News Grifols' Clayton plant to work on COVID-19 treatment
25 MAR, 2020 Reuters Spain's Grifols to Test Plasma Therapy for COVID-19 With U.S. FDA
25 MAR, 2020 Bloomberg Grifols to Work With FDA, Collect Plasma From Covid-19 Patients

 

Inquiries

Journalist or media professional?

Our media relations team is available at:
media@grifols.com 
(+34) 93 571 00 02
Restricted to media inquiries only
Potential COVID-19 Plasma Therapies in Clinical Trials

Developing and trialing an anti-SARS-CoV-2 hyperimmune globulin and convalescent plasma as a direct transfusion therapy, and evaluating the potential efficacy of currently available plasma-derived therapies.

Read more
COVID-19 Screening test

Grifols has developed a molecular test to detect the SARS-CoV-2 virus and distributes two immunological tests that identify antibodies to support COVID-19 diagnosis.

Read more